AI biotech company Owkin announced a partnership with pharma giant AstraZeneca to develop an AI-powered tool designed to prescreen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides.
According to Owkin, BRCA testing, which identifies mutations in the BRCA1 and BRCA2 genes, plays an important role in deciding a person's risk for developing certain cancers,...
Truepill has tapped Sid Viswanathan as its next CEO. This news comes after the digital pharmacy announced a $142 million funding deal in October.
A cofounder of the company, Viswanathan started Truepill in 2016. Since then he served as the company's president. In this new position, he will handle day-to-day operations. He is taking over for fellow cofounder Umar Afridi, who will continue to have...
Dublin-based medical adherence firm HealthBeacon to go public
Irish medtech firm HealthBeacon has announced plans to raise up to €25 million with an initial public offering (IPO) on Euronext Dublin’s growth market.
The company, which offers adherence solutions for injectable medications, will have a market value of around €100 million at the time of its planned flotation next month.
It expects...
This morning Owkin, a medical research company that uses machine learning, announced that its Series A funding round has reached $70 million. This comes after Mubadala Capital and Bpifrance entered with a late $18 million in investment.
The Series A has been in the works for some time. The money has trickled in periodically. In May it announced a $25 million dollar raise. But the Series A round...
Digital research platform Owkin scored $25 million in funding yesterday. The round was led by Bpifrance Large Venture with participation from Cathay Innovation and MACSF.
The platform aims to connect doctors, researchers, scientists and other stakeholders. It uses artificial intelligence to help create data sets and distribute the information to the stakeholders. Its main product, Owkin Studio,...
Rally’s new benefits platform. This weekend at SXSW, Rally Health announced the launch of a new digital, consumer-focused wellness platform. The system helps users view, access and manage their employee benefits within a single interface, while offering employers a tool to drive health engagement.
“Today we’re taking our Rally platform to a new level by making traditionally disparate elements of...
Owkin, the predictive analytics startup backed by Alphabet’s GV, has announced the launch of its AI-powered medical research network. Comprised of 30 US and EU hospitals and research institutions, the Owkin Loop Network looks to help researchers train their predictive health models on a greater scale of real-world data, as well as share any insights gained between participating researchers and...
Geisinger CEO David Feinberg is moving over to Google to head up its healthcare sector. Yesterday Geisinger announced that Feinberg is stepping down and Dr. Jaewon Ryu will be taking over as interim president and CEO of the organization.
While Geisinger's announcement was relatively vague about what Feinberg will be doing at Google, CNBC reports that his job will entail streamlining and...
Correction: A previous version of this story misstated the funding amount. The story has been updated to accurately reflect that Owkin raised $5 million in funding.
New York City-based Owkin, which uses machine learning to enhance biomedical research, has raised $5 million in Series A follow-on funds. GV, the venture arm of Alphabet formerly known as Google Ventures, was the sole investor. After...
Owkin, a predictive analytics company that aims to accelerates drug discovery and development, just landed $11 million in Series A funding. The round was led by Otium Venture with participation from Cathay Innovation, Plug and Play, and NJF Capital. This announcement brings the company’s total funding to $13.1 million.
“I am proud of the substantial progress OWKIN has made over the last year,...
